Italian Pediatrician's Consent Document on anti-Rotavirus vaccines;Documento di consenso dei Pediatri Italiani sulla vaccinazione anti-Rotavirus

Minerva Pediatrica

Volumn 60, Issue 1, 2008, Pages 3-16

  Guarino, A ^a   Ansaldi, F ^b   Ugazio, A ^c   Chiamenti, G ^d   Bona, G ^e   Correra, A ^f   Di Pietro, P ^e   Mele, G ^d   Sapia, M G ^e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Federazione Italiana Medici Pediatri ^*

^e Societa Italiana di Pediatria   (Italy)

^f Ospedale SS Annunziata   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

CONFERENCE PAPER; DOCUMENTATION; DRUG EFFICACY; HUMAN; IMMUNOGENETICS; INCIDENCE; ITALY; MEDICAL INFORMATION; MEDICAL SOCIETY; PREVALENCE; PUBLIC HEALTH SERVICE; ROTAVIRUS; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS INFECTION;

ADMINISTRATION, ORAL; HUMANS; ITALY; PEDIATRICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOCIETIES, MEDICAL; VACCINES, ATTENUATED;

EID: 42049102610     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by Rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
2. Santos N, Hoshino Y. Global distribution of Rotavirus serotypes/genotypes and its implication for the development and implementation of an effective Rotavirus vaccine. Rev Med Virol 2005;15:29-56.
3. Giaquinto C, Van Damme P, Huet F, Gothefors L, Maxwell M, Todd P et al.; REVEAL Study Group. Clinical consequences of Rotavirus Acute Gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007;195(1 Suppl):S26-35.
4. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
5. Parashar UD; Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-6.
6. Committee on Infectious Diseases. Prevention of Rotavirus Disease: Guidelines for use of Rotavirus vaccine. Pediatrics 2007;119:171-81.
7. Soriano-Gabarrò M, Mrukowicsz J, Vesikari T, Verstraeten T. Burden of Rotavirus disease in European Union Countries. Pediatr Infect Dis J 2006;25(1 Suppl):S7-S11.
8. Ehlken B, Laubereau B, Karmaus W, Petersen G, Rohwedder A, Forster J; RoMoD Study Group. Prospective population-based study on Rotavirus disease in Germany. Acta Paediatr 2002;91:769-75.
9. Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M; REVEAL Study Group. Multicenter prospective study of the burden of Rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL Study. J Infect Dis 2007;195(1 Suppl):S4-16.
10. Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr 2007;166:241-7.
11. Chandran A, Heizen RR, Santosham M, Siberry GK. Nosocomial Rotavirus infections: a systematic review. J Pediatr (Rio J) 2006;149:441-7.
12. Blutt SE, Matson DO, Crawford SE, Staat MA, Azimi P, Bennett BL et al. Rotavirus antigenemia in children is associated with viremia. PLoS Med 2007;4:e121.
13. Troncone R, Auricchio S. Rotavirus and celiac diseasexlues to the pathogenesis and perspectives on prevention. J Pediatr Gastroenterol Nutr 2007;44:527-8.
14. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L et al.. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40.
15. Blomqvist M, Juhela S, Erkkila S, Korhonen S, Simell T, Kupila A et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 year of life. Clin Exp Immunol 2002;128:511-5.
16. Ahmed T, Sumazaki R, Shin K, Nagai Y, Shibasaki M, Fuchs GJ et al. Humoral immune and clinical responses to food antigens following acute diarrhoea in children. J Paediatr Child Health 1998;34:229-32.
17. Fontana M, Zuin G, Pancheri P, Fusco FC, Lambertini A, Berni Canani R; SIGEP Working Group on Intestinal Infections. Costs associated with outpatient diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP). Dig Liver Dis 2004;36:523-7.
18. Marocco A, Assael B, Gabutti G, Guarino A, Lo palco PL, Marchetti F et al. Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes. Ig Sanita Pubbl 2006;62:215-44.
19. Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z et al. Nosocomial Rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired Rotavirus disease. Pediatr Infect Dis J 2006;25(1 Suppl):S12-21.
20. Gianino P, Mastretta E, Longo P, Laccisaglia A, Sartore M, Russo R et al. Incidence of nosocomial Rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. J Hosp Infect 2002;50:13-7.
21. Biermann KP, Neri S, Reali MF, De Martino M, Festini F. Incidence of nosocomial Rotavirus infections in a pediatric hospital over a 3-year period. Minerva Pediatr 2006;58:477-82.
22. Desselberger U, Wolleswinkel-van den Bosch W, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T. Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J 2006;25(1 Suppl):S30-41.
23. Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M; REVEAL study group. Distribution of Rotavirus genotypes in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007;195:S17-25.
24. Giaquinto C, Van Damme O, Huet F, Gothefors L, der Wielen M; REVEAL study group. Costs of community-acquired pediatric Rotavirus gastroenteritis in 7 European Countries: the REVEAL study. J Infect Dis 2007;195(1 Suppl)S36-44.
25. Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z et al. Nosocomial Rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired Rotavirus disease. Pediatr Infect Dis J 2006:25(1 Suppl):S12-21.
26. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA et al.; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral Rotavirus vaccine. N Engl J Med 2001;344:564-72.
27. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant Rotavirus vaccine. N. Engl J Med 2006;345:23-33.
28. Ruiz Palacios GM, Pérez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe Rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
29. Vesikari T, Karvonen A, Korhonen T, Espo M, Lebacq E, Forster J et al. Safety and immunogenicity of RLX4414 live attenuated human Rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 2004;22:2836-42.
30. Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R et al. ESPID/ESPGHAN Evidence-based recommendations for Rotavirus vaccination in Europe. JPGN 2008 [in press].
31. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323-32.
32. Goveis MG, Rodriguez Z, Dallas M, Robbin FI, Boslego JW, Heaton PM et al. Safety and efficacy of the prevalent Human bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 2007;26:1099-104.
33. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception:the role of age at the time of vaccination. J Infect Dis 2005;192(1 Suppl):S36-43.
34. Centers for Disease Control and Prevention (CDC). Postmarketing monitoring of intussusception after RotaTeq vaccination - United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep 2007;56:218-22.
35. Atkins D, Best D, Briss PA, Eccles M, FalckYtter Y, Flottorp S et al.; GRADE Working group. Grading quality of evidence and strength of recommendations. Br Med J 2004;328:1490.
36. Guyatt G, Schunemann HJ, Cook D, Jaeschke R, Pauker S. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126: S179-S87.
37. Committee on Infectious Diseases. Prevention of Rotavirus Disease: Guidelines for use of Rotavirus vaccine. Pediatrics 2007;119:171-81.
38. Parashar UD, Alexander JP, Glass RI. Prevention of Rotavirus gastroenteritis among infants and children. MMWR 2006;55(RR-12):1-13.
39. WHO. Rotavirus vaccine. Wkly Epidemiol Rec 2007;32:285-96.
40. Kudjawu Y, Levy-Bruhl D, Pastore Cementano L, O' Flanagan D, Salmaso S, Lo Palco P et al.; Bacci S on behalf of the VENICE working group. The current status of HPV and Rotavirus vaccines in national immunisation schedules in the EU-preliminary results of a VENICE survey. Eurosurveillance Wkly 2007;12;E070426.1.
41. ICONA 2003 - Indagine nazionale sulla copertura vaccinale e altri argomenti di salute nel secondo anno di vita [Internet]. [updated 2007 Dec 20] Available from: http://www.epicentro.iss.it/1/temi/vaccinazioni/sintesi-icona. asp.
42. Esposito S, Marchisio P, Droghetti R, Lambertini L, Faelli N, Bosis S et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 2006;24:5251-5.
43. Commissione parlamentare per l'infanzia. L'indagine conoscitiva sulla copertura vaccinale in età pediatrica e sull'ospedalizzazione dei bambini affetti da malattie infettive [Internet]. 2003 Sep 16 [updated 2008 Jan 02; cited 2007]. Available from: http://www.camera.it/_dati/leg14/lavori/ documentiparlamentari/indiceetesti/017bis/003/pdf002.pdf; www.sip.it/lucene/ search
44. Van Damme P, Van der Wielen M, Ansaldi F, Desgrandchamps D, Domingo JD, Sanchez FG et al. Rotavirus vaccines: considerations for successful implementation in Europe. Lancet Infect Dis 2006;6:805-12.
45. Lo Vecchio A, Bracale I, Albano F, Guarino A. Providing information to physicians and customers is the key strategy for promoting vaccination. Post Publication peer reviews to Will pediatricians adopt the new Rotavirus vaccine? Pediatrics 2007;119:1-10.
46. Hoeprich PD, Jordan CM, Ronald ATR. Infectious Disease. Philadalphia: Lippincott;
47. Harrington M, Butler K, Cafferkey M. Rotavirus infection in hospitalised children: incidence and impact on health care resources. Ir J Med Sci 2003;172:33-6.